Department of Emergency Medicine, Alameda Health System, Highland Hospital, Oakland, CA.
Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX.
Ann Emerg Med. 2018 Jul;72(1):29-40.e2. doi: 10.1016/j.annemergmed.2017.11.027. Epub 2018 Jan 6.
Newer combination HIV antigen-antibody tests allow detection of HIV sooner after infection than previous antibody-only immunoassays because, in addition to HIV-1 and -2 antibodies, they detect the HIV-1 p24 antigen, which appears before antibodies develop. We determine the yield of screening with HIV antigen-antibody tests and clinical presentations for new diagnoses of acute and established HIV infection across US emergency departments (EDs).
This was a retrospective study of 9 EDs in 6 cities with HIV screening programs that integrated laboratory-based antigen-antibody tests between November 1, 2012, and December 31, 2015. Unique patients with newly diagnosed HIV infection were identified and classified as having either acute HIV infection or established HIV infection. Acute HIV infection was defined as a repeatedly reactive antigen-antibody test result, a negative HIV-1/HIV-2 antibody differentiation assay, or Western blot result, but detectable HIV ribonucleic acid (RNA); established HIV infection was defined as a repeatedly reactive antigen-antibody test result and a positive HIV-1/HIV-2 antibody differentiation assay or Western blot result. The primary outcomes were the number of new HIV diagnoses and proportion of patients with laboratory-defined acute HIV infection. Secondary outcomes compared reason for visit and the clinical presentation of acute HIV infection.
In total, 214,524 patients were screened for HIV and 839 (0.4%) received a new diagnosis, of which 122 (14.5%) were acute HIV infection and 717 (85.5%) were established HIV infection. Compared with patients with established HIV infection, those with acute HIV infection were younger, had higher RNA and CD4 counts, and were more likely to have viral syndrome (41.8% versus 6.5%) or fever (14.3% versus 3.4%) as their reason for visit. Most patients with acute HIV infection displayed symptoms attributable to acute infection (median symptom count 5 [interquartile range 3 to 6]), with fever often accompanied by greater than or equal to 3 other symptoms (60.7%).
ED screening using antigen-antibody tests identifies previously undiagnosed HIV infection at proportions that exceed the Centers for Disease Control and Prevention's screening threshold, with the added yield of identifying acute HIV infection in approximately 15% of patients with a new diagnosis. Patients with acute HIV infection often seek ED care for symptoms related to seroconversion.
较之前的仅抗体免疫测定法,新的 HIV 抗原抗体联合检测可在感染后更早地检测到 HIV,因为除了 HIV-1 和 -2 抗体外,它们还可检测 HIV-1 p24 抗原,该抗原在抗体产生之前出现。我们确定了美国急诊部(ED)中使用 HIV 抗原抗体检测进行筛查的效果,以及新诊断的急性和已确立的 HIV 感染的临床表现。
这是一项回顾性研究,涉及 6 个城市的 9 个 ED,这些 ED 都有 HIV 筛查项目,在 2012 年 11 月 1 日至 2015 年 12 月 31 日期间整合了基于实验室的抗原抗体检测。确定了新诊断为 HIV 感染的独特患者,并将其分类为急性 HIV 感染或已确立的 HIV 感染。急性 HIV 感染的定义为反复出现的抗原抗体检测结果,阴性 HIV-1/HIV-2 抗体分化检测或 Western blot 结果,但可检测到 HIV 核糖核酸(RNA);已确立的 HIV 感染的定义为反复出现的抗原抗体检测结果和阳性 HIV-1/HIV-2 抗体分化检测或 Western blot 结果。主要结局是新 HIV 诊断的数量和实验室定义的急性 HIV 感染患者的比例。次要结局比较了就诊原因和急性 HIV 感染的临床表现。
共筛查了 214524 例 HIV 患者,其中 839 例(0.4%)新诊断为 HIV 感染,其中 122 例(14.5%)为急性 HIV 感染,717 例(85.5%)为已确立的 HIV 感染。与已确立的 HIV 感染患者相比,急性 HIV 感染患者更年轻,RNA 和 CD4 计数更高,更有可能因病毒综合征(41.8%对 6.5%)或发热(14.3%对 3.4%)就诊。大多数急性 HIV 感染患者出现与急性感染相关的症状(中位数症状数为 5[四分位距 3 至 6]),发热常伴有大于或等于 3 种其他症状(60.7%)。
ED 使用抗原抗体检测进行筛查,可发现以前未诊断的 HIV 感染,其比例超过疾病控制与预防中心的筛查阈值,约 15%的新诊断患者可额外发现急性 HIV 感染。急性 HIV 感染患者常因与血清转化相关的症状而到 ED 就诊。